Literature DB >> 7674912

Endocrine abnormalities of obesity.

P Björntorp1.   

Abstract

Studies have shown that patients with central obesity have increased cortisol secretion, probably because they have increased activity of the hypothalamic-pituitary-adrenal (HPA) axis. A high waist-to-hip ratio (WHR) is associated with low production of sex steroids, such as testosterone in men, and a low rate of secretion of growth hormone. High levels of cortisol and insulin combined with low levels of growth hormone and sex steroid can cause lipid accumulation. These hormonal changes probably produce more deposition of visceral than subcutaneous fat. Patients who are deficient in either testosterone or growth hormone show a reduction in visceral adiposity when their hormone levels are normalized. Stress has been shown to activate the HPA axis and may cause the hormonal changes associated with obesity. Individuals with elevated WHR have indications of high levels of stress and anxiety. Monkeys that were stressed by social disruption were found to have increased cortisol levels and low sex steroid levels. Many of these animals had insulin resistance and visceral adiposity. Stimulants, such as alcohol and smoking, also increase the activity of the HPA axis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7674912     DOI: 10.1016/0026-0495(95)90315-1

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  22 in total

1.  Short-term treatment with estrone oleate in liposomes (Merlin-2) does not affect the expression of the ob gene in Zucker obese rats.

Authors:  C Adán; M M Grasa; C Cabot; M Esteve; R Vilà; R Masanés; J Estruch; J A Fernández-López; X Remesar; M Alemany
Journal:  Mol Cell Biochem       Date:  1999-07       Impact factor: 3.396

Review 2.  Pharmacological approaches for the treatment of obesity.

Authors:  José-Antonio Fernández-López; Xavier Remesar; Màrius Foz; Marià Alemany
Journal:  Drugs       Date:  2002       Impact factor: 9.546

3.  Metabolic characterization of overweight and obese adults.

Authors:  Katie R Hirsch; Abbie E Smith-Ryan; Malia N M Blue; Meredith G Mock; Eric T Trexler; Kristin S Ondrak
Journal:  Phys Sportsmed       Date:  2016-11       Impact factor: 2.241

4.  Specific increase in leptin production in obese (falfa) rat adipose cells.

Authors:  Sophie Turban; Isabelle Hainault; Johan Truccolo; Jocelyne Andre; Pascal Ferre; Annie Quignard-Boulange; Michèle Guerre-Millo
Journal:  Biochem J       Date:  2002-02-15       Impact factor: 3.857

Review 5.  Central nervous system regulation of eating: Insights from human brain imaging.

Authors:  Olivia M Farr; Chiang-Shan R Li; Christos S Mantzoros
Journal:  Metabolism       Date:  2016-02-06       Impact factor: 8.694

6.  Impact of Adiposity and Fat Distribution on the Dynamics of Adrenocorticotropin and Cortisol Rhythms.

Authors:  Ferdinand Roelfsema; Alberto M Pereira; Johannes D Veldhuis
Journal:  Curr Obes Rep       Date:  2014-12

Review 7.  11beta-Hydroxysteroid dehydrogenase Type 1 in obesity and Type 2 diabetes.

Authors:  T M Stulnig; W Waldhäusl
Journal:  Diabetologia       Date:  2003-12-03       Impact factor: 10.122

8.  Adiposity and dietary intake in cardiovascular risk in an obese population from a Mediterranean area.

Authors:  M Garaulet; C Marín; F Pérez-Llamas; M Canterasl; F J Tebar; S Zamora
Journal:  J Physiol Biochem       Date:  2004-03       Impact factor: 4.158

9.  Evaluation of serum leptin levels and thyroid function in morbidly obese patients treated with bariatric surgery.

Authors:  S Alagna; M L Cossu; A Masala; M M Atzeni; M Ruggiu; F M Satta; E Fais; P P Rovasio; G Noya
Journal:  Eat Weight Disord       Date:  2003-06       Impact factor: 4.652

Review 10.  Sex differences in salivary cortisol in response to acute stressors among healthy participants, in recreational or pathological gamblers, and in those with posttraumatic stress disorder.

Authors:  Jason J Paris; Christine Franco; Ruthlyn Sodano; Brian Freidenberg; Elana Gordis; Drew A Anderson; John P Forsyth; Edelgard Wulfert; Cheryl A Frye
Journal:  Horm Behav       Date:  2009-06-16       Impact factor: 3.587

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.